Insider and congress filings
Charles River Laboratories International, Inc. (CRL)
About Charles River Laboratories International, Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Chief executive
- Birgit Girshick
- Employees
- 19,000
- Listed since
- Jun 23, 2000
- Market value
- $13.4B
- Price to earnings
- -
- Earnings per share
- -$4.92
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 4, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 5, 2026 | $3.02 | $2.74 | $1.0B | $977.2M | EPS beatRevenue beat |
| Q1 FY2026reported May 7, 2026 | $2.06 | $1.96 | $995.8M | $977.5M | EPS beatRevenue beat |
| Q4 FY2025reported Feb 18, 2026 | $2.39 | $2.33 | $994.2M | $987.0M | EPS beatRevenue in line |
| Q3 FY2025reported Nov 5, 2025 | $2.43 | $2.32 | $1.0B | $987.2M | EPS beatRevenue beat |
| Q2 FY2025reported Aug 6, 2025 | $3.12 | $2.50 | $1.0B | $968.9M | EPS beatRevenue beat |
| Q1 FY2025reported May 7, 2025 | $2.34 | $2.06 | $984.2M | $958.8M | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| FMR LLC | $961.5M | 4,239,752 | +22.7% | 8.74% |
| Blackrock, Inc. | $861.5M | 3,798,560 | -1.6% | 7.83% |
| Vanguard Capital Management LLC | $714.2M | 3,149,288 | -1.7% | 6.50% |
| Invesco Ltd. | $676.9M | 2,984,785 | +24.5% | 6.16% |
| Harris Associates L P | $508.3M | 2,241,144 | +4.1% | 4.62% |
| Vanguard Portfolio Management LLC | $501.4M | 2,210,979 | -3.6% | 4.56% |
| Allspring Global Investments Holdings, LLC | $436.5M | 1,905,247 | -4.4% | 3.93% |
| State Street Corp | $422.8M | 1,864,284 | -0.5% | 3.85% |
| Dimensional Fund Advisors LP | $373.8M | 1,648,450 | -0.2% | 3.40% |
| Ariel Investments, LLC | $341.6M | 1,506,185 | +4.3% | 3.11% |
| Price T Rowe Associates Inc | $341.4M | 1,505,370 | +33.8% | 3.10% |
| Geode Capital Management, LLC | $295.6M | 1,305,738 | +0.0% | 2.69% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
10 filings of 362 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| James C. FosterDirector | Sold | 33,561 | $300.00 | $10.1M | Aug 25, 2026 | 2d |
| Shannon M. ParisottoCevp, Disc & Safety Assessment | Sold | 2,039 | $294.12 | $600K | Aug 19, 2026 | 1d |
| Nancy C. AndrewsDirector | Sold | 573 | $285.24 | $163K | Aug 18, 2026 | 2d |
| Birgit GirshickChief Executive Officer | Sold | 6,500 | $279.90 | $1.8M | Aug 11, 2026 | 2d |
| Shannon M. ParisottoCevp, Disc & Safety Assessment | Sold | 3,714 | $279.66 | $1.0M | Aug 11, 2026 | 2d |
| James C. FosterDirector | Sold | 28,733 | $275.00 | $7.9M | Aug 10, 2026 | 1d |
| Victoria L. CreamerEVP & Chief People Officer | Sold | 4,179 | $259.16 | $1.1M | Aug 6, 2026 | 4d |
| Michael Gunnar KnellSVP, Finance and CAO | Sold · 9 lines | 6,645 | $260.38 | $1.7M | Aug 6, 2026 | 4d |
| Shannon M. ParisottoCevp, Disc & Safety Assessment | Sold | 5,046 | $263.00 | $1.3M | Aug 5, 2026 | 1d |
| James C. FosterDirector | Sold | 75,000 | $225.00 | $16.9M | Jun 29, 2026 | 2d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in CRL
20 disclosures of 27 on record · median 29d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +84.5%S&P +3.2% · vs S&P 500 +81.4% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +74.3%S&P +20.7% · vs S&P 500 +53.6% | Mar 30, 2026 | Apr 7, 2026 | 8d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +51.5%S&P +12.5% · vs S&P 500 +39.0% | Feb 5, 2026 | Mar 9, 2026 | 32d |
| Jefferson Shreve | Stock | Purchase | $15,001 - $50,000 | +96.9%S&P +35.0% · vs S&P 500 +62.0% | May 8, 2025 | Jun 22, 2025 | 45d |
| Jefferson Shreve | Stock | Sale | $15,001 - $50,000 | +94.5%S&P +30.8% · vs S&P 500 +63.8% | May 12, 2025 | Jun 22, 2025 | 41d |
| Robert Bresnahan | Stock | Sale | $1,001 - $15,000 | +100.4%S&P +29.1% · vs S&P 500 +71.3% | May 15, 2025 | May 31, 2025 | 16d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +162.8%S&P +41.9% · vs S&P 500 +120.9% | Apr 15, 2025 | May 12, 2025 | 27d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +100.2%S&P +40.4% · vs S&P 500 +59.7% | Apr 9, 2025 | May 12, 2025 | 33d |
| Robert Bresnahan | Stock | Purchase | $15,001 - $50,000 | +125.2%S&P +53.5% · vs S&P 500 +71.7% | Apr 8, 2025 | May 8, 2025 | 30d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +63.2%S&P +36.4% · vs S&P 500 +26.8% | Mar 12, 2025 | Apr 10, 2025 | 29d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +64.4%S&P +33.1% · vs S&P 500 +31.4% | Mar 6, 2025 | Apr 10, 2025 | 35d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +66.6%S&P +28.3% · vs S&P 500 +38.3% | Feb 25, 2025 | Mar 6, 2025 | 9d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +68.7%S&P +24.3% · vs S&P 500 +44.4% | Feb 19, 2025 | Mar 6, 2025 | 15d |
| Julie JohnsonJoint | Stock | Purchase | $1,001 - $15,000 | +60.1%S&P +28.6% · vs S&P 500 +31.5% | Jan 15, 2025 | Feb 12, 2025 | 28d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +65.5%S&P +25.7% · vs S&P 500 +39.8% | Jan 22, 2025 | Feb 6, 2025 | 15d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +70.2%S&P +27.6% · vs S&P 500 +42.7% | Jan 17, 2025 | Feb 6, 2025 | 20d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +54.3%S&P +76.3% · vs S&P 500 -21.9% | Nov 3, 2023 | Dec 6, 2023 | 33d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +43.9%S&P +78.5% · vs S&P 500 -34.6% | Oct 2, 2023 | Nov 8, 2023 | 37d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | +39.4%S&P +71.2% · vs S&P 500 -31.8% | Sep 8, 2023 | Oct 10, 2023 | 32d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | +48.4%S&P +87.9% · vs S&P 500 -39.5% | Apr 25, 2023 | May 19, 2023 | 24d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
1 member · estimate, as of Sep 10, 20261 member reports a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Robert Bresnahan | Republican · House | $15,001 - $50,000 | 0.3% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| James C. FosterDirector | Option exercise | 33,561 | Aug 25, 2026 |
| Birgit GirshickChief Executive Officer | Gift | 528 | Aug 19, 2026 |
| Shannon M. ParisottoCevp, Disc & Safety Assessment | Option exercise | 2,039 | Aug 19, 2026 |
| Nancy C. AndrewsDirector | Option exercise | 573 | Aug 18, 2026 |
| Birgit GirshickChief Executive Officer | Option exercise | 6,500 | Aug 11, 2026 |
| Shannon M. ParisottoCevp, Disc & Safety Assessment | Option exercise | 3,714 | Aug 11, 2026 |
| Joseph W. LaPlumeEVP, Corp Strategy & Develop | Gift | 257 | Aug 10, 2026 |
| James C. FosterDirector | Option exercise | 28,733 | Aug 10, 2026 |
| Victoria L. CreamerEVP & Chief People Officer | Option exercise | 4,179 | Aug 6, 2026 |
| Michael Gunnar KnellSVP, Finance and CAO | Option exercise | 2,345 | Aug 6, 2026 |
| James C. FosterDirector | Gift | 183,361 | Jun 5, 2026 |
| Birgit GirshickChief Executive Officer | Gift | 3,386 | Jun 5, 2026 |
| Shannon M. ParisottoCevp, Disc & Safety Assessment | Gift | 1,529 | Jun 5, 2026 |
| Steven BargDirector | Stock award | 422 | Jun 2, 2026 |
| Victoria L. CreamerEVP & Chief People Officer | Tax withholding | 194 | May 31, 2026 |
| Glenn ColemanEVP & Chief Financial Officer | Stock award | 6,640 | May 29, 2026 |
| Mark MintzEVP, Chief Information Officer | Stock award | 2,534 | May 29, 2026 |
| Mark MintzEVP, Chief Information Officer | Tax withholding | 305 | May 30, 2026 |
| Mark MintzEVP, Chief Information Officer | Tax withholding | 64 | May 31, 2026 |
| Joseph W. LaPlumeEVP, Corp Strategy & Develop | Stock award | 5,257 | May 29, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling CRL?
Across the 10 most recent open-market filings shown here, 0 were purchases and 10 were sales.
Which members of Congress have traded CRL?
Ro Khanna, Jefferson Shreve, Robert Bresnahan, Julie Johnson, Lois Frankel disclosed CRL transactions in the filings shown here.
Which members of Congress hold CRL?
1 member of Congress reports a position in CRL in the estimate we hold as of Sep 10, 2026. The largest estimated position belongs to Robert Bresnahan. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is CRL in the S&P 500 or the Nasdaq 100?
Charles River Laboratories International, Inc. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are CRL trades disclosed?
Insider filings on this page reached the public a median of 2 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 29 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.